Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 710.00
-5.70 (-0.80%)
Jul 9, 2025, 3:27 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 286.61 million as of July 9, 2025. Its market cap has decreased by -16.83% in one year.
Market Cap
286.61M
Enterprise Value
-154.03M
Revenue
7.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
710.00
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 286.61M, an increase of 11,986.59%. That is a compound annual growth rate of 25.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 65.07B |
| Danel (Adir Yeoshua) | 2.94B |
| Kamada | 1.49B |
| Bait Bakfar | 1.11B |
| BrainsWay | 835.64M |
| SofWave Medical | 752.68M |
| Ilex Medical | 717.16M |
| Novolog (Pharm-Up 1966) | 701.90M |